- Company Overview for CYTOSPIRE THERAPEUTICS LIMITED (14688240)
- Filing history for CYTOSPIRE THERAPEUTICS LIMITED (14688240)
- People for CYTOSPIRE THERAPEUTICS LIMITED (14688240)
- Charges for CYTOSPIRE THERAPEUTICS LIMITED (14688240)
- More for CYTOSPIRE THERAPEUTICS LIMITED (14688240)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
21 Oct 2024 | PSC07 | Cessation of 4Bio Ventures Iii Gp Llp as a person with significant control on 3 October 2024 | |
11 Oct 2024 | SH01 |
Statement of capital following an allotment of shares on 3 October 2024
|
|
31 Jul 2024 | AA | Accounts for a small company made up to 31 March 2024 | |
11 Jul 2024 | MR04 | Satisfaction of charge 146882400001 in full | |
05 Mar 2024 | CS01 | Confirmation statement made on 23 February 2024 with updates | |
26 Feb 2024 | MA | Memorandum and Articles of Association | |
22 Jan 2024 | RESOLUTIONS |
Resolutions
|
|
15 Dec 2023 | MA | Memorandum and Articles of Association | |
15 Dec 2023 | RESOLUTIONS |
Resolutions
|
|
06 Dec 2023 | PSC02 | Notification of 4Bio Ventures Iii Gp Llp as a person with significant control on 30 November 2023 | |
06 Dec 2023 | PSC07 | Cessation of Mark Uden as a person with significant control on 30 November 2023 | |
06 Dec 2023 | SH01 |
Statement of capital following an allotment of shares on 30 November 2023
|
|
06 Dec 2023 | PSC07 | Cessation of Natalie Marianne Mount as a person with significant control on 30 November 2023 | |
06 Dec 2023 | AP01 | Appointment of Mr Owen Philip Smith as a director on 22 November 2023 | |
22 Aug 2023 | MR01 | Registration of charge 146882400002, created on 18 August 2023 | |
04 Jul 2023 | MR01 | Registration of charge 146882400001, created on 29 June 2023 | |
26 May 2023 | MA | Memorandum and Articles of Association | |
26 May 2023 | RESOLUTIONS |
Resolutions
|
|
22 May 2023 | PSC02 | Notification of Abingworth Bioventures 8 Gp Lp as a person with significant control on 28 April 2023 | |
17 May 2023 | AP01 | Appointment of Dr Balaji Muralidhar as a director on 2 May 2023 | |
17 May 2023 | SH01 |
Statement of capital following an allotment of shares on 2 May 2023
|
|
21 Mar 2023 | AA01 | Current accounting period extended from 28 February 2024 to 31 March 2024 | |
24 Feb 2023 | NEWINC |
Incorporation
Statement of capital on 2023-02-24
|